Sen. Sheldon Whitehouse Sells Lam Research Co. (NASDAQ:LRCX) Stock

Senator Sheldon Whitehouse (D-Rhode Island) recently sold shares of Lam Research Co. NASDAQ: LRCX. In a filing disclosed on January 08th, the Senator disclosed that they had sold between $15,001 and $50,000 in Lam Research stock on December 19th.

Senator Sheldon Whitehouse also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of NVIDIA NASDAQ: NVDA on 1/6/2025.
• Sold $15,001 - $50,000 in shares of Apple NASDAQ: AAPL on 12/19/2024.
• Sold $1,001 - $15,000 in shares of MetLife NYSE: MET on 11/19/2024.
• Sold $1,001 - $15,000 in shares of Kenvue NYSE: KVUE on 11/18/2024.
• Purchased $15,001 - $50,000 in shares of Eli Lilly and Company NYSE: LLY on 10/30/2024.
• Sold $1,001 - $15,000 in shares of Starbucks NASDAQ: SBUX on 10/29/2024.
• Sold $1,001 - $15,000 in shares of Walt Disney NYSE: DIS on 10/29/2024.
• Sold $1,001 - $15,000 in shares of Honeywell International NASDAQ: HON on 10/29/2024.
• Sold $1,001 - $15,000 in shares of Mastercard NYSE: MA on 10/29/2024.
• Sold $1,001 - $15,000 in shares of Verizon Communications NYSE: VZ on 10/29/2024.

Lam Research Price Performance

Shares of Lam Research stock traded down $0.48 on Thursday, reaching $77.04. 8,688,460 shares of the stock were exchanged, compared to its average volume of 10,258,223. The firm's 50 day moving average is $74.72 and its 200-day moving average is $82.01. The firm has a market cap of $99.13 billion, a PE ratio of 24.90, a P/E/G ratio of 1.22 and a beta of 1.45. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.74 and a current ratio of 2.53. Lam Research Co. has a one year low of $68.87 and a one year high of $113.00.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, October 23rd. The semiconductor company reported $0.86 earnings per share for the quarter, beating analysts' consensus estimates of $0.81 by $0.05. Lam Research had a return on equity of 50.60% and a net margin of 26.02%. The firm had revenue of $4.17 billion for the quarter, compared to the consensus estimate of $4.06 billion. During the same quarter last year, the business posted $6.85 EPS. The company's revenue was up 19.7% compared to the same quarter last year. As a group, analysts anticipate that Lam Research Co. will post 3.5 EPS for the current fiscal year.

Lam Research Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 8th. Shareholders of record on Wednesday, December 11th were issued a $0.23 dividend. This represents a $0.92 annualized dividend and a yield of 1.19%. The ex-dividend date of this dividend was Wednesday, December 11th. Lam Research's dividend payout ratio is currently 29.77%.

Institutional Trading of Lam Research

Hedge funds have recently modified their holdings of the stock. Rise Advisors LLC acquired a new position in shares of Lam Research during the fourth quarter valued at about $54,000. Modus Advisors LLC acquired a new position in Lam Research during the 4th quarter worth approximately $59,000. Quarry LP raised its stake in Lam Research by 175.0% during the 2nd quarter. Quarry LP now owns 88 shares of the semiconductor company's stock worth $94,000 after buying an additional 56 shares during the period. General Partner Inc. grew its stake in Lam Research by 900.0% in the fourth quarter. General Partner Inc. now owns 1,740 shares of the semiconductor company's stock valued at $126,000 after acquiring an additional 1,566 shares during the period. Finally, Versant Capital Management Inc bought a new stake in shares of Lam Research during the fourth quarter valued at approximately $159,000. Institutional investors own 84.61% of the company's stock.

Analysts Set New Price Targets

LRCX has been the topic of several research reports. BNP Paribas raised shares of Lam Research to a "hold" rating in a report on Thursday, October 24th. UBS Group lowered their price target on shares of Lam Research from $125.00 to $115.00 and set a "buy" rating for the company in a report on Thursday, September 12th. Sanford C. Bernstein cut their price objective on Lam Research from $95.00 to $85.00 and set a "market perform" rating on the stock in a report on Friday, November 29th. Cantor Fitzgerald reiterated a "neutral" rating and issued a $100.00 target price on shares of Lam Research in a research report on Thursday, October 24th. Finally, Stifel Nicolaus restated a "buy" rating and set a $100.00 price target (down from $105.00) on shares of Lam Research in a report on Thursday, October 24th. Eight equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, Lam Research has an average rating of "Moderate Buy" and an average target price of $97.24.

About Senator Whitehouse

Sheldon Whitehouse (Democratic Party) is a member of the U.S. Senate from Rhode Island. He assumed office on January 3, 2007. His current term ends on January 3, 2025. Whitehouse (Democratic Party) is running for re-election to the U.S. Senate to represent Rhode Island. He declared candidacy for the 2024 election. Whitehouse previously served as the Rhode Island attorney general from 1999 to 2003. Before that, he was a United States attorney from 1994 to 1998. He was nominated to the position by President Bill Clinton (D). Whitehouse was a superdelegate to the 2016 Democratic National Convention from Rhode Island. He cast his vote for Hillary Clinton. As of a 2014 analysis of multiple outside rankings, Whitehouse is an average Democratic member of Congress, meaning he will vote with the Democratic Party on the majority of bills.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.